Puylaert Kevin Insider Trades & Stock Holdings

Chief Sales Officer · SOPHiA GENETICS SA · Latest filing Oct 5, 2026

Puylaert Kevin, Chief Sales Officer at SOPHiA GENETICS SA has 1 Form 4 trade on file since Oct 5, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($1.74K), net -$1.74K. Latest filing: disposed of 216 shares of $SOPH on Oct 5, 2026 at $8.04.

Trades on file

1

Open-market bought

$0

Open-market sold

$1.74K

Net open-market

-$1.74K

Latest filing

Oct 5, 2026

All insider trades by Puylaert Kevin

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 5, 2026	$SOPH	Sell (Open-market sale)	216	$8.04	$1.74K			-12.0%			Chief Sales Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Puylaert Kevin traded

• $SOPH

Frequently asked questions

Has Puylaert Kevin been buying or selling stock?

Puylaert Kevin has 0 open-market purchases and 1 open-market sale on file, net -$1.74K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Puylaert Kevin's latest insider trade?

disposed of 216 shares of $SOPH on Oct 5, 2026 at $8.04.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.